Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Sergi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|January 1, 1989
An understudied population: the homelessJ S Sergi, M Murray, P H Cotanch
Journal of the National Cancer Institute|January 17, 1990
Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group studyR M Bukowski, P Goodman, E D Crawford, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
Cancer|February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinomaR M Bukowski, G Inoshita, P Yalavarthi, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Cancer Research|August 15, 1991
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinomaR M Bukowski, W Sharfman, S Murthy, et al.
Cancer Research|February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancyR M Bukowski, J S Sergi, W J Sharfman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|January 1, 1989
An understudied population: the homelessJ S Sergi, M Murray, P H Cotanch
Journal of the National Cancer Institute|January 17, 1990
Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group studyR M Bukowski, P Goodman, E D Crawford, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
Cancer|February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinomaR M Bukowski, G Inoshita, P Yalavarthi, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Cancer Research|August 15, 1991
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinomaR M Bukowski, W Sharfman, S Murthy, et al.
Cancer Research|February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancyR M Bukowski, J S Sergi, W J Sharfman, et al.
Pageof 1